Biotherapy: the fourth modality of cancer treatment.

Biotherapy: the fourth modality of cancer treatment. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Biotherapy: the fourth modality of cancer treatment. Abstract Text:

R K Oldham,

Biotherapy represents a new modality of cancer treatment. It utilizes biologicals and biological response modifiers in the treatment of cancer. Many of these substances are of "natural" origin emanating from mammalian cells as physiologic mediators of immune response and as substances active in the regulation of growth and maturation. With the advent of molecular biological techniques, hybridoma technology, and computer applications, it is now possible to prepare these biological substances in highly purified form and in large quantities for use as medicinals. The expertise required to apply these biotherapeutic approaches to the treatment of cancer often involves the use of immunological and/or molecular biological capabilities. Because of the rather specialized expertise needed to understand and apply these substances as anticancer approaches, those individuals with expertise in the application of chemotherapy to patients with cancer are not necessarily well prepared for the translation of biotherapy to the clinic. Biotherapeutic approaches are broad and involve a whole range of physiological responses inherent in cancer biology. The approaches necessary to bring these biotherapeutic capabilities to the clinic need to be considered carefully, and the use of new techniques and new methods of application should be encouraged so as not to inhibit these potentially powerful anticancer approaches. As natural mediators, many biologicals have much less inherent toxicity than the drugs previously used in systemic cancer therapy. Therefore, the systems for translating these substances from the laboratory to the clinic should be restructured for the rapid translation of biotherapy to the patient.

Biotherapy: the fourth modality of cancer treatment. Publishing Authors By Initials

RK Oldham,

For similar complex mixtures: tissue extracts: thymus extracts research abstracts see: complex mixtures: tissue extracts: thymus extracts research

PUBMED ID PMID:

MEDLINE DATE:

Biotherapy: the fourth modality of cancer treatment. Journal Published:

PUBLICATION TYPE: Review

Journal: Journal of cellular physiology. Supplement

VOLUME: 4

Page Numbers: 91-9

Journal Abbreviation:

ISSN: 0737-1462

DAY: 12

MONTH: 02

YEAR: 1986

Biotherapy: the fourth modality of cancer treatment. Information

Number of References: 46

LANGUAGE: eng

NlmUniqueID: 8300145

Biotherapy: the fourth modality of cancer treatment. Keywords Mesh Terms:

KEYWORDS: Thymus Extracts

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Biotherapy: the fourth modality of cancer treatment. Information

Substance Name: Interferons

Registry Number: 9008-11-1

Grant and Affiliation Information for Biotherapy: the fourth modality of cancer treatment.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Cell Physiol Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Biotherapy: the fourth modality of cancer treatment Related Publications

• An iterative method for training multilayer networks with threshold functions.
• Aneurysm of the ductus arteriosus in the neonate.
• Benchmarking a novel ultrasound-CT fusion system for respiratory motion management in radiotherapy: assessment of spatio-temporal characteristics and comparison to 4DCT.
• Biotherapy: the fourth modality of cancer treatment.
• Cardiac volvulus: plain film recognition of an often fatal condition.
• Cervical spine ROM measurements: optimizing the testing protocol by using a 3D ultrasound-based motion analysis system.
• Comorbid personality disorder and treatment use in a community sample of youths: a 20-year follow-up.
• Comparison of Analytical and Numerical Particle Deposition Using Commercial CFD Packages: Impaction and Sedimentation.
• Corrections to "image recovery and segmentation using competitive learning in a layered network.
• Damage-Limited Lifetime of 193-nm Lithography Tools as a Function of System Variables.
• Drosophila aging 2006/2007.
• Editorial: 2008: state of affairs for cancer biotherapy & radiopharmaceuticals.
• Functional imaging in bulk tissue specimens using optical emission tomography: fluorescence preservation during optical clearing.
• High-dose methotrexate in combination chemotherapy for small cell lung cancer.
• INSULIN TREATMENT OF SCHIZOPHRENIA--A CONTROLLED STUDY.
• Image recovery and segmentation using competitive learning in a layered network.
• Inhalation of concentrated ambient particulate matter near a heavily trafficked road stimulates antigen-induced airway responses in mice.
• Insulin treatment of schizophrenia. A three-year follow-up of a controlled study.
• Launching DSM-V.
• Managing broiler litter application rate and grazing to decrease watershed runoff losses.
• Managing broiler litter application rate and grazing to decrease watershed runoff losses.
• Mycetoma of the lung in a cavity that developed from a gunshot wound.
• Preface.
• Quantitative determination of lysozyme-ligand binding in the solution and gas phases by electrospray ionisation mass spectrometry.
• Research and treatment synergism.
• The aetiology of depression and anxiety.
• The brighter side.
• The problem of consistent radiological diagnosis in coalminers' pneumoconiosis; an experimental study.
• The psychophysics of clinical pain.
• The reliability of isometric strength and fatigue measures in patients with knee osteoarthritis.